Publication Details

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia.

Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, Stone RM, Kalaycio M, Scheinberg DA, Steinherz P, Sievers EL, Coutré S, Dahlberg S, Ellison R, Warrell RP. J Clin Oncol. 2001; 19 (18): 3852-60

To determine the safety and efficacy of arsenic trioxide (ATO) in patients with relapsed acute promyelocytic leukemia (APL).

PubMedID: 11559723